Biopharmaceutical
Pharmaceutical
Health
Global Blood Therapeutics
$49.519876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$49.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$3.00 (-5.71%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell GBT and other stocks, options, ETFs, and crypto commission-free!
About
Global Blood Therapeutics, Inc. Common Stock, also called Global Blood Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Read More It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.
CEO
Employees
171
Headquarters
South San Francisco, California
Founded
2011
Market Cap
2.92B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.01M
High Today
$52.34
Low Today
$49.28
Open Price
$52.27
Volume
268.60K
52 Week High
$54.88
52 Week Low
$30.15
Collections
Biopharmaceutical
Pharmaceutical
Health
Therapy
Biotechnology
Medical
Technology
2015 IPO
News
MarketBeatMar 8
Stock Price, News, & Analysis for Global Blood Therapeutics
Media coverage about GBT stock has trended positive this week, according to InfoTrie. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Global Blood Therapeutics earned a daily sentiment score of 2.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that rec...
Price Paid on Robinhood
11% Higher
Right Now
52 Week Low
$30.15
Average Price Paid
$44.50
52 Week High
$54.88
Earnings
-$0.94
-$0.81
-$0.68
-$0.55
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 7, After Hours